BQST · Bioquest Corp
$0.07
At close · Sep 15
Going-concern doubt
— flagged Sep 12, 2022
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the accompanying financial statements, the Company had an accumulated deficit as of July 31, 2022, of $10,788,321 and its liabilities exceeded its assets by $536,419 These factors among others raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Sep 12, 2022
Market Cap
$1.97M
Shares
29.90M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.07
Open$0.07
Day$0.07–0.07
Available close range$0.07–1.00
Avg vol 30d2K
Short int40 · 0.0% float · 1.0d
Short vol100%
DataJan 2020–Sep 2026
Filing10-Q · Sep 12
The closing range uses available history since Oct 14, 2025; less than a full year is stored.
Up next
filed Sep 12, 2022
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$30,977
Trailing 12 months
Net income (TTM)
−$507,406
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$14,955
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+38.8%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.4 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−92%
below
RSI (14)
27
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−92%
trailing
6-month return
−95%
trailing
YTD return
−87%
this year
Relative strength
−111%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · ▲ +300.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
4614%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
281.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−92%
Bearish
RSI (14)
27
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · ▲ +300.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its available closing range
Range low $0
Now $0 · 0%
Range high $1
vs 50-day avg -92%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BQST
this stock
Bioquest Corp
|
$1.97M | — | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
CCXI
Churchill Capital Corp XI
|
$684.55M | — | — | — | 6.7% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$647.19M | +2.8% | — | — | 0.2% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$602.01M | +2.7% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BQST | -86.9% | -92.4% | -94.6% | +1.5% | -86.9% |
| SPY | -1.1% | -2.0% | +16.0% | -1.3% | +11.1% |
| vs SPY | -85.8% | -90.4% | -110.6% | +2.8% | -98.0% |